EBN&Co. represented Red Dot Capital on the deal.Red Dot Capital led a $27 million Series C funding round in Supplant, a startup that develops a system that monitors…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
